Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved Tumor Control Following Radiosensitization with Ultrasound-Sensitive Oxygen Microbubbles and Tumor Mitochondrial Respiration Inhibitors in a Preclinical Model of Head and Neck Cancer.
Lacerda Q, Falatah H, Liu JB, Wessner CE, Oeffinger B, Rochani A, Leeper DB, Forsberg F, Curry JM, Kaushal G, Keith SW, O'Kane P, Wheatley MA, Eisenbrey JR. Lacerda Q, et al. Among authors: curry jm. Pharmaceutics. 2023 Apr 21;15(4):1302. doi: 10.3390/pharmaceutics15041302. Pharmaceutics. 2023. PMID: 37111787 Free PMC article.
Tumoral oxygenation and biodistribution of Lonidamine oxygen microbubbles following localized ultrasound-triggered delivery.
Lacerda Q, Rochani A, Oeffinger B, Liu JB, Wessner CE, Tahmasebi A, Falatah H, Lee P, Leeper DB, Forsberg F, Curry J, Keith SW, O'Kane P, Kaushal G, Wheatley MA, Eisenbrey JR. Lacerda Q, et al. Int J Pharm. 2022 Sep 25;625:122072. doi: 10.1016/j.ijpharm.2022.122072. Epub 2022 Aug 3. Int J Pharm. 2022. PMID: 35932933 Free PMC article.
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Ali AS, Manukian G, Johnson JM, Vathiotis I, Axelrod R, Keith SW, Curry J, Cognetti D, Luginbuhl A, Argiris A, Bar-Ad V. Ali AS, et al. Among authors: curry j. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):181-185. doi: 10.1016/j.ijrobp.2023.03.065. Epub 2023 Apr 3. Int J Radiat Oncol Biol Phys. 2023. PMID: 37019367 Clinical Trial. No abstract available.
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
Johnson JM, Vathiotis IA, Harshyne LA, Ali A, Bar Ad V, Axelrod R, Lorber E, Curry J, Cognetti DM, Luginbuhl AJ, Tuluc M, Keith S, Mahoney MG, Argiris A. Johnson JM, et al. Among authors: curry j. J Immunother Cancer. 2023 Aug;11(8):e007141. doi: 10.1136/jitc-2023-007141. J Immunother Cancer. 2023. PMID: 37536941 Free PMC article. Clinical Trial.
Tumor microenvironment in head and neck squamous cell carcinoma.
Curry JM, Sprandio J, Cognetti D, Luginbuhl A, Bar-ad V, Pribitkin E, Tuluc M. Curry JM, et al. Semin Oncol. 2014 Apr;41(2):217-34. doi: 10.1053/j.seminoncol.2014.03.003. Epub 2014 Mar 5. Semin Oncol. 2014. PMID: 24787294 Free article.
Analysis of cost and outcomes in bony versus soft tissue midface free flap reconstruction.
Alnemri A, Philips R, Sussman S, Xu V, Givens A, Patel A, Swendseid B, Agarwal A, Keith S, Shimada A, Selman Y, Cognetti DM, Heffelfinger R, Goldman R, Luginbuhl AJ, Wax MK, Sweeny L, Curry JM. Alnemri A, et al. Among authors: curry jm. Head Neck. 2022 Aug;44(8):1896-1908. doi: 10.1002/hed.27112. Epub 2022 Jun 6. Head Neck. 2022. PMID: 35665975
204 results